Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Abstract WP218: Building Buy-In for 90-Day mRS in Intracerebral Hemorrhage Patients
0
Zitationen
8
Autoren
2026
Jahr
Abstract
Background: Intracerebral hemorrhage (ICH) accounts for 10% of strokes and is the most fatal subtype. Unlike ischemic stroke, adoption of quality metrics for ICH has lagged. The 90-day modified Rankin Score (mRS) measures functional outcomes, but its use in ICH patients is rarely reported or tracked as a hospital outcome measure. Objective: The American Heart Association (AHA) partnered with twenty-two Comprehensive Stroke Centers in a three-year initiative to improve ICH data collection and identify barriers to capturing 90-day mRS. The goal was to establish standardized strategies and unified messaging to increase hospital adoption and emphasize the value of tracking post-acute outcomes, facilitate quality improvement, and promote adoption of guideline-directed care. Methods: A survey assessed barriers, motivators, and perceived importance of 90-day mRS collection. Standardized justification tools were created, including a slide deck, SMART goal framework, and shared resources such as telephone scripts, triage algorithms, and EHR optimizations. Get With The Guidelines®-Stroke registry demonstrations highlighted strategies for efficient workflow integration. Results: Survey responses identified barriers including exclusion of ICH patients from workflows, ischemic-focused certification standards, staffing shortages, and limited awareness of research gaps. Respondents emphasized the importance of data capture as essential for outcome comparisons, evidence-based stroke care, and evaluation of acute ICH management. Implementing justification toolkits provides a foundation for hospital adoption of 90-day mRS capture, with opportunities to amplify this work nationally.
Ähnliche Arbeiten
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
1993 · 12.065 Zit.
Correspondence - Tranexamic acid for traumatic brain injury
2005 · 11.684 Zit.
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 · 11.613 Zit.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.546 Zit.
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
1991 · 8.400 Zit.